ExSight Ventures logo

ExSight Ventures

North America, New York, United States, New York

Description

ExSight Ventures is a venture capital firm focused on investing in technologies that preserve and restore vision.

Investor Profile

ExSight Ventures has made 13 investments, with 1 in the past 12 months and 15% as lead.

Stage Focus

  • Series A (54%)
  • Series B (31%)
  • Series C (8%)
  • Seed (8%)

Country Focus

  • United States (85%)
  • United Kingdom (15%)

Industry Focus

  • Therapeutics
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Market Research
  • Medical Device
  • Genetics
  • Life Science
  • Developer Tools
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ExSight Ventures frequently co-invest with?

Access Biotechnology
North America, New York, United States, New York
Co-Investments: 2
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
Capital Community Angel Investors
North America, Michigan, United States, East Lansing
Co-Investments: 3
Aju IB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Yeoksamdong
Co-Investments: 2
M
North America, Michigan, United States, Ann Arbor
Co-Investments: 3
Bios Partners
North America, Texas, United States, Fort Worth
Co-Investments: 3
Visionary Venture Fund
North America, California, United States, Aliso Viejo
Co-Investments: 3
InFocus Capital Partners
North America, New York, United States, Jericho
Co-Investments: 5
Biosciences Research and Commercialization Center (BRCC)
North America, Michigan, United States, Kalamazoo
Co-Investments: 3
Kaitai Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 2

What are some of recent deals done by ExSight Ventures?

Horizon Surgical Systems

Malibu, California, United States

Horizon Surgical Systems develops AI-driven, imaging-guided surgical robotics for microsurgery.

Artificial Intelligence (AI)Health CareRobotics
Series AOct 16, 2024
Amount Raised: $30,000,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 8, 2023
Amount Raised: $15,000,000
Re-Vana Therapeutics

Belfast, Belfast, United Kingdom

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

Health CareMarket ResearchMedicalTherapeutics
Series ANov 30, 2022
Amount Raised: $12,075,997
Valitor

Berkeley, California, United States

Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..

BiotechnologyDeveloper ToolsMedicalTherapeutics
Series BOct 5, 2022
Amount Raised: $28,000,000
DTx Pharma

San Diego, California, United States

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

BiotechnologyPharmaceuticalTherapeutics
Series BMar 1, 2021
Amount Raised: $100,000,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BDec 22, 2020
Amount Raised: $46,900,000
Re-Vana Therapeutics

Belfast, Belfast, United Kingdom

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

Health CareMarket ResearchMedicalTherapeutics
SeedJun 2, 2020
Amount Raised: $3,250,000
DTx Pharma

San Diego, California, United States

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

BiotechnologyPharmaceuticalTherapeutics
Series AJan 6, 2020
Amount Raised: $10,600,000
Trefoil Therapeutics

San Diego, California, United States

Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.

BiotechnologyHealth CareTherapeutics
Series AJul 16, 2019
Amount Raised: $28,000,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AMay 17, 2017
Amount Raised: $4,250,000